Half of U.S. adults with diabetes say managing diabetes is more difficult during the holidays versus other times of the year
Long-Term Glycemic Control Cuts Risk for Severe COVID-19 With T2DM
Additionally, use of corticosteroids or combo of metformin and insulin significantly cut intensive care risk
Glucose-Regulating Drugs Aid COVID-19 Outcomes in Patients With Diabetes
Findings include GLP-1R agonists and pioglitazone use, with drop in hospital admissions
ADA: Peds Hospitalization Rates for New-Onset T2DM Up During Pandemic
Hospitalization rate for new onset diabetes up from 0.27 percent in 2019 to 0.62 percent in 2020; mean admission HbA1c, glucose also higher
T2DM in Middle Age Ups Mortality Risk in COVID-19 Infection
Excess COVID-19 death risk from type 2 diabetes decreases with increasing age
Euglycemic DKA ID’d in T2DM Patients With COVID-19
Five cases of euDKA identified in patients with type 2 diabetes using SGLT2 inhibitors who developed SARS-CoV-2 infection
Risk of Severe COVID-19 Up Among Those With Diabetes
Risk for severe COVID-19 similar among those with type 1 and type 2 diabetes
AHA: Sotagliflozin Beneficial for T2DM With Heart Failure
Second study shows benefits among patients with type 2 diabetes and chronic kidney disease, risks for CVD
Sitagliptin May Cut Mortality in T2DM Patients With COVID-19
Sitagliptin at time of hospitalization linked to reduced mortality, improved clinical outcomes